Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 307

1.

The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.

Wasmuth HE, Tag CG, Van de Leur E, Hellerbrand C, Mueller T, Berg T, Puhl G, Neuhaus P, Samuel D, Trautwein C, Kanse SM, Weiskirchen R.

Hepatology. 2009 Mar;49(3):775-80. doi: 10.1002/hep.22707.

PMID:
19105210
[PubMed - indexed for MEDLINE]
2.

Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.

Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM.

Liver Int. 2009 May;29(5):686-91. doi: 10.1111/j.1478-3231.2008.01897.x. Epub 2008 Oct 15.

PMID:
19018983
[PubMed - indexed for MEDLINE]
3.

The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.

Sedding D, Daniel JM, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus RC, Tillmanns H, Weimer T, Preissner KT, Kanse SM.

J Exp Med. 2006 Dec 25;203(13):2801-7. Epub 2006 Dec 4.

PMID:
17145954
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.

Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT.

Thromb Haemost. 2008 Feb;99(2):286-9. doi: 10.1160/TH07-10-0640. Review.

PMID:
18278176
[PubMed - indexed for MEDLINE]
5.

Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.

Shibamiya A, Muhl L, Tannert-Otto S, Preissner KT, Kanse SM.

Biochem J. 2007 May 15;404(1):45-50.

PMID:
17300216
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.

Muhl L, Galuska SP, Oörni K, Hernández-Ruiz L, Andrei-Selmer LC, Geyer R, Preissner KT, Ruiz FA, Kovanen PT, Kanse SM.

FEBS J. 2009 Sep;276(17):4828-39. doi: 10.1111/j.1742-4658.2009.07183.x. Epub 2009 Jul 31.

PMID:
19664058
[PubMed - indexed for MEDLINE]
7.

Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP.

Muhl L, Nykjaer A, Wygrecka M, Monard D, Preissner KT, Kanse SM.

Biochem J. 2007 Jun 1;404(2):191-6.

PMID:
17298300
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.

Borkham-Kamphorst E, Zimmermann HW, Gassler N, Bissels U, Bosio A, Tacke F, Weiskirchen R, Kanse SM.

J Hepatol. 2013 Jan;58(1):104-11. doi: 10.1016/j.jhep.2012.09.007. Epub 2012 Sep 16.

PMID:
22989567
[PubMed - indexed for MEDLINE]
9.

Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced proliferation of human hepatic myofibroblasts.

Park SD, Jung JH, Lee HW, Kwon YM, Chung KH, Kim MG, Kim CH.

Int Immunopharmacol. 2005 Mar;5(3):555-69.

PMID:
15683851
[PubMed - indexed for MEDLINE]
10.

Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation.

Ben-Ari Z, Tambur AR, Pappo O, Sulkes J, Pravica V, Hutchinson I, Klein T, Tur-Kaspa R, Mor E.

Transplantation. 2006 Feb 15;81(3):392-7.

PMID:
16477226
[PubMed - indexed for MEDLINE]
11.

Changes in factor VII-activating protease in a bleomycin-induced lung injury rat model and its influence on human pulmonary fibroblasts in vitro.

Mu E, Liu X, Chen S, Zhi L, Li X, Xu X, Ma X.

Int J Mol Med. 2010 Oct;26(4):549-55.

PMID:
20818495
[PubMed - indexed for MEDLINE]
12.

Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.

Kannemeier C, Al-Fakhri N, Preissner KT, Kanse SM.

FASEB J. 2004 Apr;18(6):728-30. Epub 2004 Feb 20.

PMID:
14977886
[PubMed - indexed for MEDLINE]
Free Article
13.

Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.

Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E.

Dig Liver Dis. 2005 May;37(5):349-56.

PMID:
15843085
[PubMed - indexed for MEDLINE]
14.

Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism.

Hoppe B, Tolou F, Radtke H, Kiesewetter H, Dörner T, Salama A.

Blood. 2005 Feb 15;105(4):1549-51. Epub 2004 Oct 14.

PMID:
15486068
[PubMed - indexed for MEDLINE]
Free Article
15.

Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.

Willeit J, Kiechl S, Weimer T, Mair A, Santer P, Wiedermann CJ, Roemisch J.

Circulation. 2003 Feb 11;107(5):667-70.

PMID:
12578864
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis.

Verma-Gandhu M, Peterson MR, Peterson TC.

Eur J Pharmacol. 2007 Oct 31;572(2-3):220-7. Epub 2007 Jun 30.

PMID:
17678645
[PubMed - indexed for MEDLINE]
17.

Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.

Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH.

J Viral Hepat. 2009 Feb;16(2):141-8. doi: 10.1111/j.1365-2893.2008.01052.x. Epub 2008 Oct 24.

PMID:
19175868
[PubMed - indexed for MEDLINE]
18.

Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B.

Lou SM, Li YM, Wang KM, Cai WM, Weng HL.

World J Gastroenterol. 2004 Feb 1;10(3):385-8.

PMID:
14760763
[PubMed - indexed for MEDLINE]
Free Article
19.

Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.

Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG.

Medicine (Baltimore). 2009 Nov;88(6):349-57. doi: 10.1097/MD.0b013e3181c10477.

PMID:
19910749
[PubMed - indexed for MEDLINE]
20.

Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies.

Halangk J, Berg T, Neumann K, Sarrazin C, Hinrichsen H, Fitz C, Puhl G, Mueller T, Neuhaus P, Wiedenmann B, Witt H.

Genet Test Mol Biomarkers. 2009 Jun;13(3):407-14. doi: 10.1089/gtmb.2008.0135.

PMID:
19473084
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk